华 魏

Dr. 华 魏

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WZWeiqing Zeng
Weiqing Zeng
LZLiangji Zhou
Liangji Zhou
GTGangjian Tang
Gangjian Tang
SCSheng Chai
Sheng Chai
XCXiaoqiao Che
Xiaoqiao Che
华魏华 魏
华 魏
Although the association between red blood cell (RBC) folate and osteoarthritis (OA) is still controversial, relevant evidence is continuously emerging. This study aimed to examine the relationship between RBC folate levels and the incidence of OA in adults aged 40–60. This cross-sectional analysis involved 7708 adults from the National Health and Nutrition Examination Survey 2009–2018. The independent variable was RBC folate, which reflects long-term folate status, and the outcome variable was the odds of OA. A logistic regression model was used to evaluate the association between RBC folate levels and the incidence of OA. Additionally, subgroup analyses were conducted by race, gender, and body mass index. After adjusting for other potential confounding factors, there was a positive association between RBC folate and the incidence of OA (OR 1.0024, 95% CI 1.0012–1.0036, P < 0.0001). When RBC folate was divided into four equal groups, in the fully adjusted model, participants in the highest quartile had a significant higher odds of OA than those in the lowest quartile (OR 1.3157, 95% CI 1.0532–1.6436, P = 0.0191). In adults aged 40 to 60 years, there was a J-shaped relationship between RBC folate and the incidence of OA (turning point: 102 nmol/dL, OR 1.0403, 95% CI 1.0242–1.0566, p < 0.0001). This indicates that when the RBC folate level exceeds 102 nmol/dL, for every 10 nmol/dL increase, the odds of OA rises by 4.03%. Our findings showed a positive association between RBC folate and the incidence of OA in adults aged 40–60. Further studies are required to explore its underlying mechanism and confirm this correlation.

9 January 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
WZWeiqing Zeng
Weiqing Zeng
ZJZiqi Jin
Ziqi Jin
HLHongmei Li
Hongmei Li
LZLiangji Zhou
Liangji Zhou
YTYongxing Tan
Yongxing Tan
GTGangjian Tang
Gangjian Tang
Objective: To compare the short-term efficacy of arthroscopic capsular release combined with five-step manipulation under anaesthesia vs. five-step manipulation under anaesthesia alone for adhesive capsulitis. Methods: This retrospective study included 66 patients assigned to arthroscopic capsular release (ACR) plus five-step manipulation under anaesthesia (MUA) ( n = 31) or five-step MUA alone ( n = 35); both cohorts received intra-articular “cocktail” irrigation. Outcome assessments comprised American Shoulder and Elbow Surgeons (ASES) scores and Visual Analogue Scale (VAS) pain scores at 1 week, 1 month, and 6 months post-operatively; peri-operative metrics included operative time, length of post-operative hospital stay, and total hospitalisation cost. Results: One week and one month post-operatively, VAS scores in the two groups were similar ( P > 0.05). At 6 months, the treatment group exhibited significantly lower VAS scores than the control group (1.83 ± 0.70 vs. 2.55 ± 0.56, 95% CI: −1.03 to −0.41, P < 0.001). ASES scores did not differ between groups at 1 week or 1 month ( P > 0.05), but were significantly higher in the treatment group at 6 months (76.68 ± 6.67 vs. 73.43 ± 2.54, 95% CI: 1.42–5.32, P = 0.009). No complications occurred in either group. Operative time, postoperative hospitalisation days and hospitalisation cost were higher in the treatment group ( P < 0.05). Conclusion: Compared with simple five-step MUA, the combination therapy of five-step MUA and ACR provides superior pain relief and higher ASES functional scores at 6 months after surgery. However, operation time, postoperative hospitalisation days and hospitalisation costs correspondingly increase. Due to the small sample size and short clinical observation time, further follow-up is needed for long-term efficacy.

13 March 2026 in Medicine
Verified
Journal Article
Open access
WZWeiqing Mm Zeng
Weiqing Mm Zeng
HMHailiang Mm Ma
Hailiang Mm Ma
华魏华 魏
华 魏
HLHongmei Li
Hongmei Li
LZLiangji Zhou
Liangji Zhou
HWHua Wei
Hua Wei
In contemporary society, the prevalence of depression among women is worsening and rising annually, influenced by numerous intricate factors. Folate, a B vitamin, is vital for overall human health. This study aimed to investigate the association between red blood cell (RBC) folate levels and depression within a nationally representative group of women in the U.S. We conducted a cross-sectional study to examine the association between depression and RBC folate levels among women in the U.S., using data from the National Health and Nutrition Examination Survey from 2009 to 2018. Participants were stratified by depressive status and categorized into 4 quartiles (Q1–Q4) based on their RBC folate levels. We built both univariate and multivariate regression models to conduct a comprehensive threshold effect analysis on the correlation between RBC folate levels and depression. We analyzed data from 9409 women in the U.S. In the fully adjusted model, when RBC folate was sorted into 4 quartiles, both the lowest (Q1: odds ratio [OR] = 1.396, 95% confidence interval [CI]: 1.135–1.717, P = .0027) and highest (Q4: OR = 1.425, 95% CI: 1.160–1.749, P = .0014) quartiles showed significantly higher odds of depression compared to the reference Q2. Threshold effect analysis identified a breakpoint at 985 nmol/L, indicating a U-shaped association between RBC folate level and depression. Below 985 nmol/L, the risk of depression significantly decreased by 6% per 100 nmol/L increase in RBC folate (OR = 0.9994, 95% CI: 0.9989–0.9999, P = .0099). Above this inflection point, the risk significantly increased by 3% per 100 nmol/L increase (OR = 1.0003, 95% CI: 1.0002–1.0005, P < .0001). A U-shaped association was observed between RBC folate and depression among women in the U.S. Maintaining appropriate RBC folate levels may help reduce depression in women. However, the mechanisms behind both RBC folate and depression still require further in-depth research.